SCHEMBL5591585

SCHEMBL5591585

COc1ccc(CN2C(=O)CC3(CCN(CC[C@H](N)c4ccccc4)CC3)C2=O)cc1

nearest known ligand 0.45

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 0.45
DRD2 P14416 1/20 0.45
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45
HTR2B P41595 1/20 0.45
OPRL1 P41146 1/20 0.42
ADRA1B P35368 1/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7014779 0.86 SIGMAR1 (0.59) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL6408859 0.85 SIGMAR1 (0.47) SIGMAR1DRD2HTR2AHTR2CHTR2B
Hydrochloric Acid SCHEMBL6414709 0.85 SIGMAR1 (0.48) SIGMAR1DRD2HTR2AHTR2CHTR2B
Hydrochloric Acid SCHEMBL5255706 0.85 SIGMAR1 (0.48) SIGMAR1DRD2HTR2AHTR2CHTR2B
Hydrochloric Acid SCHEMBL6409136 0.85 SIGMAR1 (0.48) SIGMAR1DRD2HTR2AHTR2CHTR2B
Hydrochloric Acid SCHEMBL6410306 0.85 SIGMAR1 (0.48) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL4833925 0.84 KMT2A (0.46) SIGMAR1DRD2HTR2AHTR2CHTR2B
Hydrochloric Acid SCHEMBL4833327 0.83 KMT2A (0.45) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL4836434 0.83 SIGMAR1 (0.43) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL14520045 0.83 CCR5 (0.46) SIGMAR1DRD2HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007065256-A1 NOVEL SPIROPIPERIDINE COMPOUNDS AND METHODS FOR THE MODULATION OF CHEMOKINE RECEPTOR ACTIVITY VIROCHEM PHARMA INC. (CA) 2007-06-14 WO claimed
WO-2007065256-A1 NOVEL SPIROPIPERIDINE COMPOUNDS AND METHODS FOR THE MODULATION OF CHEMOKINE RECEPTOR ACTIVITY VIROCHEM PHARMA INC. (CA) 2007-06-14 WO disclosed